New Haven, CTNCT06834217Now EnrollingIRB Ready

Obsessive Compulsive Disorder (OCD) Clinical Trial in New Haven, CT

Access cutting-edge obsessive compulsive disorder (ocd) treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this New Haven location

Preparing your pre-screening questions…

Expert Care in New Haven

Access obsessive compulsive disorder (ocd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obsessive compulsive disorder (ocd) treatment provided free

Apply for This New Haven Location

Check if you qualify for this obsessive compulsive disorder (ocd) clinical trial in New Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Haven site if eligible
  4. 4Begin participation

About This Obsessive Compulsive Disorder (OCD) Study in New Haven

Obsessive-compulsive disorder (OCD) is associated with substantial impairments in quality of life and is among the most disabling psychiatric disorders. Exposure therapy is among the first-line of treatments for obsessive-compulsive disorder (OCD) . Extinction learning is thought to be a core mechanism of therapeutic exposure. Fear and safety signal learning are traditionally associated with activity and connectivity within the canonical corticolimbic "fear circuit", which includes the amygdala, medial prefrontal cortex (mPFC), and hippocampus. Transcranial direct current stimulation (tDCS) is a neuromodulation technology that can augment brain plasticity, learning, and memory. The proposed study will test if obsessive-compulsive disorder (OCD) is associated with inhibitory safety learning deficits and if transcranial direct current stimulation (tDCS) normalizes functional connectivity and safety signal processing to recover extinction deficits in obsessive-compulsive disorder (OCD).

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

All Participant Inclusion Criteria would include:
18 years of age or older
speak English fluently, and
able to provide written and verbal informed consent.
Obsessive-compulsive disorder (OCD) Inclusion Criteria would include:
meet criteria for OCD as determined by structured clinical interview
exhibit significant current symptoms of OCD
report duration of OCD symptoms of at least 1-year
OCD symptoms are primary or co-primary relative to other psychiatric diagnoses
stable psychiatric treatment (≥8-weeks) or no active treatment.
exhibit significant current symptoms of OCD as determined by the Dimensional Obsessive-Compulsive Scale (DOCS) (≥18).

Exclusion Criteria

All Participant Exclusion Criteria would include:
active severe substance use disorder(s)
acute suicidality
history of bipolar or psychotic disorder(s)
significant developmental disabilities
loss of consciousness \> 10 minutes
history of traumatic brain injury
major neurological disease
a positive pregnancy test
other brain stimulation or magnetic resonance imaging contraindications
new psychological treatment within the past 8 weeks
daily anxiolytic medication use (e.g., benzodiazepine).
Non-Clinical Control Exclusion Criteria would include:
meet current criteria for a psychiatric disorder as determined by structured clinical interview
active-psychotropic medications.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Haven?

Yes, this clinical trial (NCT06834217) has an active research site in New Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obsessive Compulsive Disorder (OCD) Treatment Options in New Haven, CT

If you're searching for obsessive compulsive disorder (ocd) treatment options in New Haven, CT, this clinical trial (NCT06834217) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obsessive compulsive disorder (ocd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obsessive compulsive disorder (ocd) clinical trials near you to find additional studies recruiting in your area.

More OCD Trials in New Haven, CT

See all ocd clinical trials recruiting in New Haven — not just this study.

Browse OCD Trials in New Haven

Browse More Trials by Condition

Ready to Join in New Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Haven, CT